Guidance
Sickle cell and thalassaemia screening pathway requirements
An overview of the sickle cell and thalassaemia (SCT) screening end-to-end pathway.
Applies to England
Documents
Details
This document provides an overview of SCT screening by describing what should happen at each stage of the end-to-end pathway.
In this publication, we use the terms ‘woman’ and ‘women’ to refer to anyone able to become pregnant, including trans men. Trans men who are pregnant should be offered the same antenatal and newborn screening tests as other pregnant individuals.
Updates to this page
Published 21 June 2021Last updated 19 December 2024 + show all updates
-
Removed 'specification' from the title of the HTML document.
-
Removed 'specification' from the title. Changed lead organisation from Office for Health Improvement and Disparities to NHS England. Removed DHSC email address.
-
First published.